TY - JOUR
T1 - Special Considerations of Anastomotic Leaks in Crohn's Disease
AU - Jeganathan, N. Nimalan A.
AU - Koltun, Walter A.
N1 - Funding Information:
This work was supported by the Peter and Marshia Carlino Early Career Professorship Award for Inflammatory Bowel Disease Research.
Publisher Copyright:
© 2021 Georg Thieme Verlag. All rights reserved.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Rates of anastomotic leak following intestinal resections in the setting of inflammatory bowel disease are significantly influenced by clinical characteristics. While the literature can be contradictory due to significant heterogeneity in the published data, several common themes appear to consistently arise. With respect to Crohn's disease, low serum albumin, preoperative abscess, reoperative abdominal surgery, and steroid use are associated with an increased risk of postoperative intra-abdominal septic complications. On the contrary, biologic therapy, immunomodulator use, and method of anastomosis appear not to confer increased anastomotic-related complications. Undoubtedly, a low rate of anastomotic leakage is inherent to procedures within colorectal surgery but diligent attention must be paid to identify, optimize, and, therefore, reduce known risks.
AB - Rates of anastomotic leak following intestinal resections in the setting of inflammatory bowel disease are significantly influenced by clinical characteristics. While the literature can be contradictory due to significant heterogeneity in the published data, several common themes appear to consistently arise. With respect to Crohn's disease, low serum albumin, preoperative abscess, reoperative abdominal surgery, and steroid use are associated with an increased risk of postoperative intra-abdominal septic complications. On the contrary, biologic therapy, immunomodulator use, and method of anastomosis appear not to confer increased anastomotic-related complications. Undoubtedly, a low rate of anastomotic leakage is inherent to procedures within colorectal surgery but diligent attention must be paid to identify, optimize, and, therefore, reduce known risks.
UR - http://www.scopus.com/inward/record.url?scp=85116761835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116761835&partnerID=8YFLogxK
U2 - 10.1055/s-0041-1735273
DO - 10.1055/s-0041-1735273
M3 - Article
C2 - 34853563
AN - SCOPUS:85116761835
SN - 1531-0043
VL - 34
SP - 412
EP - 416
JO - Clinics in Colon and Rectal Surgery
JF - Clinics in Colon and Rectal Surgery
IS - 6
ER -